Financial Daily from THE HINDU group of publications
Wednesday, Apr 27, 2005
Financial Daily from THE HINDU group of publications Wednesday, Apr 27, 2005 |
|
|
|
|
|
Corporate
-
Announcements Marketing - Brands Ocimum launches its brand of biochips Our Bureau
Bangalore , April 26 OCIMUM Biosolutions has announced that it has launched OciChips, its brand of biochips that are used in drug testing and disease studies. The biochips were formerly known as MWG arrays. Ocimum recently acquired German genomics major MWG Biotech AG's microarrays and microarray services division for an undisclosed sum. Ms Anuradha Acharya, CEO of the Hyderabad-based life science R&D enabling company, said, "Ocimum completed the acquisition of this division recently and we are happy to continue the superior technology offered by these chips. We also plan to retain most of MWG's GD (genomic diagnosis) business customers and offer newer products and services." While these operations will continue in Germany, Ocimum said it planned to start wet lab services in India soon. Ocimum said it would takeover MWG's portfolio of biochips on the complete genomes of a range of model organisms as well as a biochip representing the complete human genome. It will handle the business of custom arrays, custom biochips and the oligo sets for clients who want to produce their own biochips. Ocimum is a certified life sciences contract research and development company active in bioinformatics, genomics, proteomics and custom contract research services. The MWG Biotech Chief Operating Officer, Dr Volker Muschalek, said, "We are very pleased to hand this highly innovative product line to Ocimum Biosolutions."
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|